PHARMACOGENOMIC IN PREGNANCY

Aim: Pharmacogenomics (PGx) is part of personalized medicine, which is a fast-developing eld of medicine. It is the study of how a patient's genetic makeup affects and how they react to drugs. In pregnancy the physiological and genetic changes will affect the drug efcacy and can cause side effects. The goal of this review is to outline the pharmacogenetics employed in current therapies, to outline recent results and research in obstetric pharmacogenetics, and to outline what is required to assure the future of pharmacogenetics and customized pharmacotherapy in pregnancy. Conclusion: Results from Pharmacogenomic tests may help ensure that medications are used safely during pregnancy and after delivery, and they may also provide mothers more assurance that their child will gain from breastfeeding. More efforts are needed to raise knowledge of testing, encourage informed decision-making, and ensure proper utilization and availability because Pharmacogenomic testing is still new many physicians and patients.